Bishop Clark T
Utah Valley Regional Medical Center, Provo, UT, 84602, United States.
Respir Med Case Rep. 2021 Apr 15;33:101413. doi: 10.1016/j.rmcr.2021.101413. eCollection 2021.
We present three cases in this report. Three adult brothers, homozygous for the delF508 cystic fibrosis mutation, have maintained an unusually preserved clinical condition even though they did not attend a CF Clinic during their childhood, do not attend a CF Clinic now, and do not follow standard CF care guidelines. The brothers use an alternative CF treatment regimen on which they have maintained normal lung function, height/weight, and bloodwork, and they utilize less than half the recommended dosage of pancreatic enzymes. The brothers culture only methicillin-sensitive Staphylococcus aureus, and have never cultured any other bacteria. Highly effective modulator therapies, such as elexacaftor/tezacaftor/ivacaftor, do not substantially reduce infection and inflammation in vivo in CF patients, and thus these three case reports are of special note in terms of suggesting adjunct therapeutic approaches. Finally, these three cases also raise important questions about standard CF care guidelines.
在本报告中,我们介绍了三个病例。三名成年兄弟,均为德尔F508囊性纤维化突变的纯合子,尽管他们在童年时期未就诊于囊性纤维化诊所,现在也未就诊,且未遵循标准的囊性纤维化护理指南,但他们的临床状况却异常良好。这三名兄弟采用了一种替代的囊性纤维化治疗方案,在此方案下他们维持了正常的肺功能、身高/体重和血液检查结果,并且他们使用的胰酶剂量不到推荐剂量的一半。这三名兄弟仅培养出对甲氧西林敏感的金黄色葡萄球菌,从未培养出任何其他细菌。像依列卡福/替扎卡福/依伐卡福这样的高效调节剂疗法,在囊性纤维化患者体内并不能显著减少感染和炎症,因此这三个病例报告在提示辅助治疗方法方面具有特别的意义。最后,这三个病例也引发了关于标准囊性纤维化护理指南的重要问题。